What is the recommended treatment for Clostridium tertium infections?

Treatment of Clostridium tertium Infections

For Clostridium tertium infections, broad-spectrum antibiotic therapy with vancomycin plus either piperacillin-tazobactam, ampicillin-sulbactam, or a carbapenem antimicrobial is recommended as initial empiric treatment, with subsequent targeted therapy based on susceptibility testing. 1, 2

Clinical Presentation and Diagnosis

• C. tertium is an aerotolerant, gram-positive, spore-forming bacillus that can be misidentified as Bacillus species or other gram-positive aerobic rods 3
• Most commonly causes bacteremia in immunocompromised patients, particularly those with neutropenia and hematological malignancies 4
• Can also cause necrotizing soft tissue infections, particularly in patients with diabetes mellitus 5
• Blood cultures and tissue cultures should be obtained before initiating antimicrobial therapy 2
• MALDI-TOF mass spectrometry can provide rapid and accurate identification of C. tertium 3

Initial Empiric Treatment

• For severe infections or necrotizing soft tissue infections:

  • Vancomycin plus either piperacillin-tazobactam, ampicillin-sulbactam, or a carbapenem (meropenem, imipenem-cilastatin, or doripenem) 1, 2
  • Urgent surgical exploration and debridement is essential for necrotizing infections 2, 6

• For bacteremia in neutropenic patients:

  • Vancomycin is considered the drug of choice due to C. tertium's resistance pattern 4
  • Consider adding a carbapenem for broader coverage, especially in critically ill patients 3

Targeted Therapy Based on Susceptibility

• C. tertium has unusual resistance patterns, typically being resistant to:

  • Many beta-lactam antibiotics
  • Clindamycin 4

• Effective antibiotics typically include:

  • Vancomycin (drug of choice) 4
  • Carbapenems (meropenem has been used successfully) 3
  • Metronidazole (for anaerobic coverage) 2

Duration of Treatment

• For bacteremia: Intravenous antibiotics initially, with transition to oral antibiotics once clinically improved 2
• Continue antibiotics for 2-3 weeks for bacteremia without complications 2
• For necrotizing soft tissue infections: Continue antibiotics until further debridement is no longer necessary, the patient has improved clinically, and fever has been resolved for 48-72 hours 6
• Procalcitonin monitoring may be useful to guide antimicrobial discontinuation 6

Special Considerations

• In non-neutropenic patients with C. tertium bacteremia, investigate for underlying gastrointestinal pathology, particularly perforated viscus 7
• For patients with liver cirrhosis, consider C. tertium as a potential pathogen even without neutropenia 8
• In diabetic patients with soft tissue infections, aggressive surgical debridement combined with appropriate antibiotics is essential 5

Monitoring and Follow-up

• Monitor blood cultures until clearance is documented 4
• Repeat imaging studies should be performed in patients with persistent bacteremia to identify undrained foci of infection 2
• For necrotizing infections, serial debridement may be necessary until infection is controlled 6